These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7751649)

  • 21. Substrate specificity of trypsin investigated by using a genetic selection.
    Evnin LB; Vásquez JR; Craik CS
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6659-63. PubMed ID: 2204062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of the active centre of coronavirus 3C-like proteases.
    Hegyi A; Friebe A; Gorbalenya AE; Ziebuhr J
    J Gen Virol; 2002 Mar; 83(Pt 3):581-593. PubMed ID: 11842253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.
    Jing H; Xu Y; Carson M; Moore D; Macon KJ; Volanakis JE; Narayana SV
    EMBO J; 2000 Jan; 19(2):164-73. PubMed ID: 10637221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of essential amino acid residues in the functional activity of poliovirus 2A protease.
    Yu SF; Lloyd RE
    Virology; 1991 Jun; 182(2):615-25. PubMed ID: 1850921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant.
    Hedstrom L; Perona JJ; Rutter WJ
    Biochemistry; 1994 Jul; 33(29):8757-63. PubMed ID: 8038165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of monoclonal antibodies as probes of the three-dimensional structure of human complement factor D.
    Niemann MA; Kearney JF; Volanakis JE
    J Immunol; 1984 Feb; 132(2):809-15. PubMed ID: 6558106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures.
    Perkins SJ; Smith KF
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):109-14. PubMed ID: 8216203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
    J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial sequence of human complement component factor B: novel type of serine protease.
    Christie DL; Gagnon J; Porter RR
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4923-7. PubMed ID: 6776529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.
    Johnson DM; Gagnon J; Reid KB
    Biochem J; 1980 Jun; 187(3):863-74. PubMed ID: 6821372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
    Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
    Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid sequence of human D of the alternative complement pathway.
    Niemann MA; Bhown AS; Bennett JC; Volanakis JE
    Biochemistry; 1984 May; 23(11):2482-6. PubMed ID: 6383466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding.
    Hourcade DE; Mitchell LM; Oglesby TJ
    J Immunol; 1999 Mar; 162(5):2906-11. PubMed ID: 10072540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and properties of human factor D.
    Volanakis JE; Barnum SR; Kilpatrick JM
    Methods Enzymol; 1993; 223():82-97. PubMed ID: 8271969
    [No Abstract]   [Full Text] [Related]  

  • 35. Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system.
    Perkins SJ; Smith KF; Kilpatrick JM; Volanakis JE; Sim RB
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):87-99. PubMed ID: 8216242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin.
    Graf L; Craik CS; Patthy A; Roczniak S; Fletterick RJ; Rutter WJ
    Biochemistry; 1987 May; 26(9):2616-23. PubMed ID: 3111531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivariate-activity mining for molecular quasi-species in a glutathione transferase mutant library.
    Kurtovic S; Runarsdottir A; Emrén LO; Larsson AK; Mannervik B
    Protein Eng Des Sel; 2007 May; 20(5):243-56. PubMed ID: 17468114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides.
    Lesavre P; Gaillard MH; Halbwachs-Mecarelli L
    Eur J Immunol; 1982 Mar; 12(3):252-4. PubMed ID: 6920299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-directed mutagenesis of putative catalytic and nucleotide binding sites in N10-formyltetrahydrofolate synthetase.
    Kounga K; Song S; Haslam GC; Himes RH
    Biochim Biophys Acta; 1996 Aug; 1296(1):112-20. PubMed ID: 8765236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
    DiBella EE; Scheraga HA
    Biochemistry; 1996 Apr; 35(14):4427-33. PubMed ID: 8605192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.